Search results for "69"

showing 10 items of 1106 documents

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease.

2019

Background & Aim There is an unmet need for non-invasive biomarkers in non-alcoholic fatty liver disease (NAFLD) that can diagnose advanced disease and identify patients suitable for clinical trials. The PRO-C3 collagen neo-epitope is a putative direct marker of fibrogenesis. We assessed the performance of PRO-C3 in a large, well-characterised international NAFLD cohort and report the development and validation of 2 novel panels for the diagnosis of advanced fibrosis (F≥3) in NAFLD, including a simplified clinical score which eliminates the need for online calculators. Methods Plasma PRO-C3 levels were determined in a prospectively recruited international cohort of 449 patients with biopsy …

medicine.medical_specialtyADVANCED FIBROSISSCORING SYSTEMPROGRESSIONGastroenterologySTEATOHEPATITIS03 medical and health sciences0302 clinical medicineFibrosisInternal medicineNAFLDBiopsyInternal MedicineImmunology and AllergyMedicineSTEATOSISPRO-C3Stage (cooking)lcsh:RC799-869030304 developmental biologySteatohepatitisRISK0303 health sciencesScience & TechnologyHepatologymedicine.diagnostic_testGastroenterology & Hepatologybusiness.industryFatty liverfibrosisGastroenterologyNASHDIABETES-MELLITUSCHRONIC HEPATITISBiomarkermedicine.disease3. Good healthClinical trialCohortBIOPSYBiomarker (medicine)030211 gastroenterology & hepatologylcsh:Diseases of the digestive system. GastroenterologySteatohepatitisbusinessLife Sciences & BiomedicineResearch ArticleJHEP reports : innovation in hepatology
researchProduct

Surgical Treatment of Coledochal Cyst Associated with an Aberrant Posterior Hepatic Duct: Report of a Case and Brief Literature Review

2011

Choledochal cysts (CCs) are rare congenital cystic or fusiform dilatations of the biliary tree that can involve the extrahepatic and/or intrahepatic biliary tree. We report a case of huge type I CC associated with an aberrant posterior hepatic duct. A 52-year-old man presented with a 3-week history of upper right abdominal pain and jaundice and serologic sign of obstructive jaundice. Ultrasonography (US), magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography were performed with the diagnosis of CC type I according to the classification of Alonso-Lej and Todani-Watanabe. The indication for surgical resection was posed. The cyst was completely resected…

medicine.medical_specialtyAbdominal painPublished: January 2011medicineCystCholedochal cystslcsh:RC799-869Magnetic resonance cholangiopancreatographyEndoscopic retrograde cholangiopancreatographymedicine.diagnostic_testbusiness.industryCholedochal cystBilio-jejunostomyGastroenterologyJaundicemedicine.diseaseSurgerySettore MED/18 - Chirurgia Generalemedicine.anatomical_structureBiliary tractSurgerylcsh:Diseases of the digestive system. GastroenterologyRadiologymedicine.symptombusinessDuct (anatomy)Case Reports in Gastroenterology
researchProduct

Endoscopic Resection of a Large Colonic Lipoma: Case Report and Review of Literature

2010

Colonic lipomas are uncommon, benign, submucosal adipose tumors that are usually asymptomatic. Large lipomas can cause symptoms such as constipation, abdominal pain, rectal bleeding and intussusception. We report the case of a 60-year-old man with a history of lower abdominal pain and pseudoobstructive symptoms. Colonoscopy revealed a large polypoid sessile lesion in the sigma. We used a standardized technique of polypectomy, preceded by submucosal injection of dilute 5 ml polygelin with epinephrine 1:10,000 solution, to fully resect large colonic lipomas. The lipoma size was 3.5 cm. No bleeding or perforation developed. Histology showed the polyp to be a submucosul lipoma. On follow-up, th…

medicine.medical_specialtyAbdominal painendoscopic resection.medicine.medical_treatmentPerforation (oil well)ColonoscopyColonic lipomaLesionIntussusception (medical disorder)medicineotorhinolaryngologic diseaseslcsh:RC799-869Literature reviewSessile Lesionmedicine.diagnostic_testcolonbusiness.industryGastroenterologyLipomamedicine.diseasePolypectomySurgeryPublished: February 2010body regionsSettore MED/18 - Chirurgia Generalestomatognathic diseasesEndoscopic resectionlcsh:Diseases of the digestive system. GastroenterologyLipomamedicine.symptombusinessCase Reports in Gastroenterology
researchProduct

Glucose 6-P dehydrogenase delays the onset of frailty by protecting against muscle damage.

2021

Background: Frailty is a major age-associated syndrome leading to disability. Oxidative damage plays a significant role in the promotion of frailty. The cellular antioxidant system relies on reduced nicotinamide adenine dinucleotide phosphate (NADPH) that is highly dependent on glucose 6-P dehydrogenase (G6PD). The G6PD-overexpressing mouse (G6PD-Tg) is protected against metabolic stresses. Our aim was to examine whether this protection delays frailty. Methods: Old wild-type (WT) and G6PD-Tg mice were evaluated longitudinally in terms of frailty. Indirect calorimetry, transcriptomic profile, and different skeletal muscle quality markers and muscle regenerative capacity were also investigate…

medicine.medical_specialtyAging[SDV]Life Sciences [q-bio]Respiratory chainOxidative phosphorylationDiseases of the musculoskeletal systemGlucosephosphate DehydrogenaseMitocondrisLipid peroxidation03 medical and health scienceschemistry.chemical_compoundMice0302 clinical medicineEnvellimentPhysiology (medical)Internal medicineAdipocytemedicineNADPHAnimalsOrthopedics and Sports MedicineRespiratory exchange ratio030304 developmental biologychemistry.chemical_classification0303 health sciencesReactive oxygen speciesDisabilityFrailtybusiness.industryMusclesQM1-695Skeletal muscleGlucose 1-DehydrogenaseGlutathioneOriginal Articles3. Good healthMitochondriamedicine.anatomical_structureEndocrinologyGlucosechemistryRC925-935Human anatomyHealthspanOriginal ArticleAntioxidantbusinessReactive oxygen species030217 neurology & neurosurgeryJournal of cachexia, sarcopenia and muscle
researchProduct

Non-celiac wheat sensitivity: rationality and irrationality of a gluten-free diet in individuals affected with non-celiac disease: a review

2021

AbstractNon-celiac gluten or wheat sensitivity (NCWS) is a “clinical entity induced by the ingestion of wheat leading to intestinal and/or extraintestinal symptoms that improve once the wheat-containing foodstuff is removed from the diet, and celiac disease and wheat allergy have been excluded”. This mostly accepted definition raises several points that remain controversial on this condition. In the present review, the authors summarize the most recent advances in the clinic and research on NCWS through an accurate analysis of different studies. We screened PubMed, Medline, Embase, and Scopus using the keywords “non-celiac gluten sensitivity”, “non-celiac wheat sensitivity”, and “diagnosis”…

medicine.medical_specialtyAllergyGlutensAllergyDuodenumReviewWheat HypersensitivityDiseaseGastroenterologyDiet Gluten-FreeInternal medicinemedicineHumansCeliac diseaselcsh:RC799-869Irritable bowel syndromechemistry.chemical_classificationbusiness.industryGastroenterologynutritional and metabolic diseasesGeneral MedicineHepatologymedicine.diseaseGlutendigestive system diseasesIrritable bowel syndromechemistryWheatEtiologyGluten freelcsh:Diseases of the digestive system. GastroenterologybusinessWheat allergyHumanBMC Gastroenterology
researchProduct

Complémentarité et équilibre de l’apport alimentaire en protéines et en lipides

2003

The nature and level of dietary protein is liable to influence cholesterol and essential fatty acid (EFA) metabolism. Dietary vegetable protein, particularly the undigested fraction, decreases intestinal cholesterol absorption, increases the faecal excretion of steroids, and enhances the catabolism of cholesterol-carrying lipoproteins by increasing the activity or number of LDL receptors. However, the hypocholesterolemic effect of protein may be due to the presence of non-protein components and hence the purity degree of the selected protein, and the concomitant addition or not of cholesterol. Dietary proteins with different amino acid composition may modulate the secretion of hormones (e.g…

medicine.medical_specialtyAntioxidantmedicine.medical_treatmentlcsh:TP670-699soy proteinBiochemistrycaseinchemistry.chemical_compoundEssential fatty acidInternal medicinemedicineessential fatty acidchemistry.chemical_classificationCatabolismChemistryCholesterolcholesterolMetabolismprotein malnutritionperoxidationEndocrinologyLDL receptorIntestinal cholesterol absorptionlipids (amino acids peptides and proteins)lcsh:Oils fats and waxesFood SciencePolyunsaturated fatty acidOléagineux, Corps gras, Lipides
researchProduct

Superior Mesenteric Artery Syndrome: Clinical, Endoscopic, and Radiological Findings.

2018

Background. The superior mesenteric artery (SMA) syndrome is a rare entity presenting with upper gastrointestinal tract obstruction and weight loss. Studies to determine the optimal methods of diagnosis and treatment are required. Aims and Methods. This study aims at analyzing the clinical presentation, diagnosis, and management of SMA syndrome. Ten cases of SMA syndrome out of 2074 esophagogastroduodenoscopies were suspected. A contrast-enhanced computed tomography (CECT) scan was performed to confirm the diagnosis. After, a gastroenterologist and a nutritionist personalized the therapy. Furthermore, we compared the demographical, clinical, endoscopic, and radiological parameters of these …

medicine.medical_specialtyArticle Subject03 medical and health sciences0302 clinical medicineWeight lossInternal medicinemedicine.arterymedicineSuperior mesenteric arterylcsh:RC799-869Prospective cohort studySettore MED/12 - GastroenterologiaHepatologybusiness.industryGastroenterologyHepatologymedicine.diseaseSMA*Settore MED/18 - Chirurgia Generale030220 oncology & carcinogenesis030211 gastroenterology & hepatologylcsh:Diseases of the digestive system. GastroenterologyRadiologysuperior mesenteryc artery syndrome endoscopic finding radiological aspectsPresentation (obstetrics)medicine.symptombusinessBody mass indexSuperior mesenteric artery syndromeGastroenterology research and practice
researchProduct

Frailty and Sarcopenia in Acute‐on‐Chronic Liver Failure

2021

In patients with cirrhosis, sarcopenia is a critical reduction in skeletal muscle mass and frailty represents a status of global physical dysfunction caused by under nutrition, muscle wasting, and functional impairment. Both are prevalent conditions in liver transplant candidates and have shown to be independent predictors of adverse outcome. Evidence supports their incorporation into clinical practice both as a prognostic factor guiding clinical decision making and as a tool to identify candidates for physical and nutritional interventions. The wide heterogeneity of instruments used for sarcopenia and frailty measurement, the absence of a single suitable instrument for sarcopenia and frail…

medicine.medical_specialtyCirrhosisHepatologybusiness.industryRC799-869ReviewDiseases of the digestive system. Gastroenterologymedicine.diseaseFrailty assessmentUnder nutritionTransplantationSarcopeniamedicineAcute on chronic liver failureIn patientmedicine.symptomIntensive care medicinebusinessWastingHepatology Communications
researchProduct

Aloe vera: not always so beneficial in patients with chronic liver disease

2013

medicine.medical_specialtyCirrosis hepaticabiologybusiness.industryGastroenterologyMEDLINEGeneral Medicinebiology.organism_classificationChronic liver diseasemedicine.diseaseGastroenterologyAloe veraChronic diseaseInternal medicinemedicineIn patientlcsh:Diseases of the digestive system. Gastroenterologylcsh:RC799-869businessRevista Espanola de Enfermedades Digestivas
researchProduct

Pulmonary metastasectomy in colorectal cancer: a prospective study of demography and clinical characteristics of 543 patients in the Spanish colorect…

2013

Objectives To capture an accurate contemporary description of the practice of pulmonary metastasectomy for colorectal carcinoma in one national healthcare system. Design A national registry set up in Spain by Grupo Espanol de Cirugia Metastasis Pulmonares de Carcinoma Colo-Rectal (GECMP-CCR). Setting 32 Spanish thoracic units. Participants All patients with one or more histologically proven lung metastasis removed by surgery between March 2008 and February 2010. Interventions Pulmonary metastasectomy for one or more pulmonary nodules proven to be metastatic colorectal carcinoma. Primary and secondary outcome measures The age and sex of the patients having this surgery were recorded with the…

medicine.medical_specialtyCirurgia colorectalMediastinal lymphadenopathyColorectal cancerMetastasisMetastasisCarcinoembryonic antigenMetàstasiCàncer colorectalColorectal surgerymedicineCarcinoma1506Prospective cohort studyPathological16941695biologybusiness.industryResearchGeneral surgeryGeneral Medicinemedicine.diseaseColorectal cancerSurgeryOncologybiology.protein1737Metastasectomy1717business
researchProduct